NL-OMON53832已完成不适用
Dotatate to locate coronary plaques at high-risk of myocardial infarction. - DOLPHI
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •- Aged 50 years and older
- •- Underwent CCTA imaging within 78 weeks from the screening visit
- •- Either CAD-RADS 4 or higher OR 0/1 on CCTA.
- •- Able to provide written informed consent
排除标准
- •- History of chronic kidney disease stage 3b - 5, defined as a CKD-EPI value of
- •< 45 ml/min/1,73m2.
- •- CVD events/revascularization in history
- •- Standard contra-indications to 68Ga-Dotatate PET, and CT based on physicians
- •experience and current practices.
研究者
相似试验
进行中（未招募）
1 期
Research with gallium dotatate PET/CT scans to image atherosclerosis in the coronary arteries.Inflammatory atherosclerosis of the coronary arteries.EUCTR2022-002269-14-NLAMC, Cardiovascular Sciences40
已完成
不适用
Dotatate to Locate Coronary Plaques at High-risk of Myocardial InfarctionAtheroscleroses, CoronaryNCT05536960Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)41
已完成
3 期
High-Resolution Assessment of Coronary Plaques in a Global Evolocumab Randomized Study (HUYGENS)anginaheart attackhigh blood lipidshigh cholesterolVessels supplying the heart with blood1001108210013317NL-OMON48805Amgen43
进行中（未招募）
1 期
Imaging of Coronary Plaques in Subjects Treated With EvolocumabDyslipidemiaEUCTR2017-003236-37-DEAmgen Inc.150
进行中（未招募）
1 期
Imaging of Coronary Plaques in Subjects Treated With EvolocumabMedDRA version: 20.0Level: PTClassification code 10058108Term: DyslipidaemiaSystem Organ Class: 10027433 - Metabolism and nutrition disordersDyslipidemiaEUCTR2017-003236-37-ITAMGEN INC.150